Chandigarh UT Health Dept Marks Inquiry Into Sale Of Branded Drugs At Jan Aushadhi Store

Chandigarh : The UT health department on Friday marked an inquiry to check on the sale of branded medicines at the Jan Aushadhi store at the Government Multi-Specialty Hospital (GMSH), Sector 16, premises.

The development came after a patient, who visited the hospital’s orthopaedics department after getting severe knee pain, filed a written complaint with the UT health director, stating that the Jan Aushadhi store gave her branded medicines in place of the generic ones and also issued a wrong bill.

“The Jan Aushadhi store sold branded medicine to me at a cost of ₹235, but gave me a bill for a purchase amounting to ₹201. The authorities must check on the sale of the store,” the patient said in her complaint.

Addressing the same, UT health secretary Yashpal Garg said, “After receiving the complaint, the drug inspector has been asked to check on the working of the Jan Aushadhi store and to submit a report.”

After the inquiry was marked, the drug inspector conducted a surprise check on the store.

The health department, in a statement said, it was observed during the inspection that the kendra had stocked both Jan Aushadhi drugs and other branded medicines for sale.

“Eight types of branded drugs were seized. Certified copies of certain purchase and sale bills for branded and generic drugs were also taken on record, as evidence of sale of both types of drugs,” it further read.

The statement stated that the matter will be investigated further and that it would consult the Pharmaceuticals and Medical Devices Bureau of India regarding the guidelines related to the sale of drugs.

“If the violations are confirmed, appropriate actions will be taken against the Jan Aushadhi Kendra,” it added.

  • Related Posts

    Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

    Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

    CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

    Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

    Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

    CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

    CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

    Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

    Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

    Puducherry drugs inspector suspended after counterfeit medicine crackdown

    Puducherry drugs inspector suspended after counterfeit medicine crackdown

    Researchers discover a compound that can boost ageing muscle repair

    Researchers discover a compound that can boost ageing muscle repair

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks